Glenn Sblendorio - Sep 13, 2023 Form 3 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role
Director
Signature
/s/ Adam Levy, Attorney-in-fact
Stock symbol
MLYS
Transactions as of
Sep 13, 2023
Transactions value $
$0
Form type
3
Date filed
9/14/2023, 04:13 PM
Previous filing
Jul 13, 2023
Next filing
Nov 13, 2023

No securities are beneficially owned.

Remarks:

EXHIBIT LIST: EX-24 Glenn Sblendorio POA